Cargando…

Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans

Detalles Bibliográficos
Autores principales:	De Sousa-Coelho, A. L., Rodriguez-Rodriguez, R., Softic, S., Jonker, J. W., Relat, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441540/ https://www.ncbi.nlm.nih.gov/pubmed/37608789 http://dx.doi.org/10.3389/fendo.2023.1253675

Ejemplares similares

Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho
por: Aaldijk, Alexandra S., et al.
Publicado: (2023)

FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
por: Tillman, Erik J., et al.
Publicado: (2020)

FGF21 and Cardiac Physiopathology
por: Planavila, Anna, et al.
Publicado: (2015)

FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
por: Henriksson, Emma, et al.
Publicado: (2020)

Obesity-resistance of UCP1-deficient mice associates with sustained FGF21 sensitivity in inguinal adipose tissue
por: Klein Hazebroek, Marlou, et al.
Publicado: (2022)

Hormone Resistance in Diabetes and Obesity: Insulin, Leptin, and FGF21
por: Flier, Jeffrey S.
Publicado: (2012)

FGF21 gene therapy as treatment for obesity and insulin resistance
por: Jimenez, Veronica, et al.
Publicado: (2018)

Association of Elevated Plasma FGF21 and Activated FGF21 Signaling in Visceral White Adipose Tissue and Improved Insulin Sensitivity in Gestational Diabetes Mellitus Subtype: A Case-Control Study
por: Wang, Ning, et al.
Publicado: (2021)

Metabolic Effects of FGF-21: Thermoregulation and Beyond
por: Ni, Bin, et al.
Publicado: (2015)

Editorial: Insulin resistance and cardiovascular disease
por: Stewart, Alan J., et al.
Publicado: (2023)

CREBH Improves Diet-Induced Obesity, Insulin Resistance, and Metabolic Disturbances by FGF21-Dependent and FGF21-Independent Mechanisms
por: Satoh, Aoi, et al.
Publicado: (2020)

Stressed Liver and Muscle Call on Adipocytes with FGF21
por: Luo, Yongde, et al.
Publicado: (2013)

The Hepatokine FGF21 Increases the Human Spermatozoa Motility
por: Bourdon, Guillaume, et al.
Publicado: (2022)

FGF21 as a Hepatokine, Adipokine, and Myokine in Metabolism and Diseases
por: Itoh, Nobuyuki
Publicado: (2014)

Nutritional Regulation of Hepatic FGF21 by Dietary Restriction of Methionine
por: Fang, Han, et al.
Publicado: (2021)

Irisin, in women and men: blood pressure, heart rate, obesity and insulin resistance
por: Almeida González, Delia, et al.
Publicado: (2023)

Editorial: Current Challenges for Targeting Brown Fat Thermogenesis to Combat Obesity
por: Yoneshiro, Takeshi, et al.
Publicado: (2020)

Improved FGF21 Sensitivity and Restored FGF21 Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Rats After Duodenal-Jejunal Bypass and Sleeve Gastrectomy
por: Liu, Qiaoran, et al.
Publicado: (2019)

Editorial: Novel therapeutic strategy against obesity by targeting thermogenic fat
por: Pan, Ruping, et al.
Publicado: (2022)

Obesity-Induced Inflammation and Insulin Resistance
por: Ota, Tsuguhito
Publicado: (2014)

Research Perspectives on the Regulation and Physiological Functions of FGF21 and its Association with NAFLD
por: Inagaki, Takeshi
Publicado: (2015)

The roles of FGF21 and GDF15 in mediating the mitochondrial integrated stress response
por: Jena, Jayashree, et al.
Publicado: (2023)

Editorial: Endocrine and Paracrine Role of FGF23 and Klotho in Health and Disease
por: Erben, Reinhold G.
Publicado: (2019)

The Nuanced Metabolic Functions of Endogenous FGF21 Depend on the Nature of the Stimulus, Tissue Source, and Experimental Model
por: Spann, Redin A., et al.
Publicado: (2022)

Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
por: Fisher, ffolliott M., et al.
Publicado: (2010)

Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications
por: Vitale, Giovanni, et al.
Publicado: (2021)

Editorial: Insulin and The Brain
por: Taouis, Mohammed, et al.
Publicado: (2019)

The Association Between FGF21 and Diabetic Erectile Dysfunction: Evidence from Clinical and Animal Studies
por: Yang, Song, et al.
Publicado: (2022)

Recent Advances in Obesity-Induced Inflammation and Insulin Resistance
por: Tateya, Sanshiro, et al.
Publicado: (2013)

Role of Innate lymphoid Cells in Obesity and Insulin Resistance
por: Chen, Hong, et al.
Publicado: (2022)

Elevated Fibroblast growth factor 21 (FGF21) in obese, insulin resistant states is normalised by the synthetic retinoid Fenretinide in mice
por: Morrice, Nicola, et al.
Publicado: (2017)

Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications
por: Sbiera, Iuliu, et al.
Publicado: (2021)

Close association between lifestyle and circulating FGF21 levels: A systematic review and meta-analysis
por: Qian, Zonghao, et al.
Publicado: (2022)

FGF21 Is Released During Increased Lipogenesis State Following Rapid-Onset Radioiodine-Induced Hypothyroidism
por: Szczepańska, Ewa, et al.
Publicado: (2022)

Insulin resistance in ischemic stroke: Mechanisms and therapeutic approaches
por: Ding, Peng-Fei, et al.
Publicado: (2022)

Obesity-Induced Insulin Resistance Is Mediated by High Uric Acid in Obese Children and Adolescents
por: Niu, Yang, et al.
Publicado: (2021)

Implication of inflammatory signaling pathways in obesity-induced insulin resistance
por: Tanti, Jean-François, et al.
Publicado: (2013)

Obesity-related kidney disease: Beyond hypertension and insulin-resistance
por: Arabi, Tarek, et al.
Publicado: (2023)

Editorial: Peripheral Regulators of Obesity
por: McAinch, Andrew J., et al.
Publicado: (2019)

Stress induced obesity: lessons from rodent models of stress
por: Patterson, Zachary R., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1vd4qj6tde34pa5kgjusorgj6b